Press Releases

Summary Toggle Chembio Awarded Grant From Paul G. Allen Family Foundation to Develop Point-of-Care Diagnostic Tests for Zika Virus and Related Febrile Illnesses

Feb 19, 2016

MEDFORD, N.Y., Feb. 19, 2016 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from philanthropist and entrepreneur Paul G. Allen to immediately initiate development of simple,
Read more

Chembio Awarded Grant From Paul G. Allen Family Foundation to Develop Point-of-Care Diagnostic Tests for Zika Virus and Related Febrile Illnesses 38.3 KB
Summary Toggle Chembio to Sell Its SURE CHECK® HIV 1/2 Assay in the United States Beginning June 1, 2016

Jan 26, 2016

Exclusive U.S. Distribution Agreement With Alere to Terminate May 31, 2016

Read more

Chembio to Sell Its SURE CHECK® HIV 1/2 Assay in the United States Beginning June 1, 2016 33.4 KB
Summary Toggle Chembio Diagnostics Reports Third Quarter Financial Results

Nov 12, 2015

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Read more

Chembio Diagnostics Reports Third Quarter Financial Results 59.8 KB
Summary Toggle Chembio to Commercialize Family of DPP® Malaria Assays

Nov 3, 2015

MEDFORD, N.Y. , Nov. 03, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced plans to commercialize multiple combination DPP ® Malaria Assays to identify plasmodium falciparum and other
Read more

Chembio to Commercialize Family of DPP® Malaria Assays 2.8 KB
Summary Toggle Chembio to Host Conference Call to Discuss Third Quarter 2015 Financial Results

Nov 2, 2015

Conference Call Scheduled for Thursday, November 12th at 10:00 a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss Third Quarter 2015 Financial Results 37.1 KB
Summary Toggle Chembio Expands Point-of-Care Platform and Launches the DPP(R) Micro Reader

Oct 21, 2015

MEDFORD, N.Y. , Oct. 21, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announced today that it has signed an agreement with opTricon ( Berlin, Germany ), a leading developer of mobile analysis devices for
Read more

Chembio Expands Point-of-Care Platform and Launches the DPP(R) Micro Reader 36.4 KB
Summary Toggle Chembio Awarded Grant From the Paul G. Allen Ebola Program to Develop a Multiplex Point-of-Care Test for Febrile Illnesses

Oct 7, 2015

MEDFORD, N.Y. , Oct. 07, 2015 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, has been awarded a grant from the Paul G. Allen Ebola Program to develop a POC test to identify multiple life-threatening febrile
Read more

Chembio Awarded Grant From the Paul G. Allen Ebola Program to Develop a Multiplex Point-of-Care Test for Febrile Illnesses 41.8 KB
Summary Toggle Chembio Diagnostics Reports Second Quarter Financial Results

Aug 6, 2015

Conference Call and Webcast Today at 10:00 a.m. Eastern Time

Read more

Chembio Diagnostics Reports Second Quarter Financial Results 64.7 KB
Summary Toggle Chembio to Host Conference Call to Discuss Second Quarter 2015 Financial Results

Jul 27, 2015

Conference Call Scheduled for Thursday, August 6th at 10:00a.m. Eastern Time

Read more

Chembio to Host Conference Call to Discuss Second Quarter 2015 Financial Results 37.2 KB
Summary Toggle Chembio's DPP(R) HIV 1/2 Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV

Jun 3, 2015

Sales of DPP(R) HIV 1/2 Assay in Europe Anticipated in Q4 2015

Read more

Chembio's DPP(R) HIV 1/2 Assay Receives CE Mark Approval for Rapid Point-of-Care Detection of HIV 46.4 KB